Seyda Gulenay Gunduz
Koç University · 111 works · 2,190 citations · h-index 18
Top works
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361
- Use of Blood Transfusion at the End of Life: Does it Have Any Effects on Survival of Cancer Patients?
- Association of Vitiligo and Response in Patients with Metastatic Malignant Melanoma on Temozolomide
- Prognostic Significance of p53 in Gastric Cancer: a Meta-Analysis
- Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres
- Robotic Devices for Minimally Invasive Endovascular Interventions: A New Dawn for Interventional Radiology
- Silk Embolic Material for Catheter‐Directed Endovascular Drug Delivery
- Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study
- Age-stratified toxicity patterns of CDK4/6 inhibitors in older women with breast cancer: Disproportionality analysis from the FAERS database
- Dystrophic Cutaneous Calcification and Metaplastic Bone Formation due to Long Term Bisphosphonate Use in Breast Cancer
- Pilomatrix carcinoma of the scalp with pulmonary metastasis: A case report of a complete response to oral endoxan and etoposide
- Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen
- Survival Results and Prognostic Factors in T4 N0-3 Non-small Cell Lung Cancer Patients According to the AJCC 7thEdition Staging System
- A Reference Finding Rarely Seen in Primary Hyperparathyroidism: Brown Tumor
- Inflammatory Myofibroblastic Tumor: A Rarely Seen Submucosal Lesion of the Stomach
- Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35)
- Prognostic Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors
- Opioid endocrinopathy: A clinical problem in patients with cancer pain
- Coexistence of Gastric Adenocarcinoma and Choriocarcinoma: Complete Response to Trastuzumab and Chemotherapy